Suppressor of fused (Su(fu)) is a conserved protein that plays a significant role in the Hedgehog (Hh) signaling pathway, a critical modulator of embryonic development and adult tissue homeostasis. Su(fu) functions primarily as a negative regulator within this pathway, modulating the activity of the Gli family of transcription factors, which are pivotal in mediating the cellular responses to Hedgehog signaling. By directly interacting with Gli proteins, Su(fu) disrupts their translocation into the nucleus, thereby inhibiting the transcription of Hedgehog target genes. This interaction is crucial for the precise control of gene expression patterns that dictate cell differentiation, proliferation, and tissue patterning. The regulatory action of Su(fu) extends beyond mere suppression of Gli-mediated transcription; it also involves the modulation of the processing and stability of Gli proteins, further emphasizing its integral role in fine-tuning Hedgehog signaling outputs. The balance maintained by Su(fu) in the Hedgehog pathway underscores its importance in developmental processes and its involvement in pathological conditions when dysregulated.
The inhibition of Su(fu) involves mechanisms that disrupt its ability to regulate Hedgehog signaling, thereby affecting the downstream cellular outcomes mediated by this pathway. Inhibition can occur through various molecular interactions that either block Su(fu) from binding to Gli proteins or alter its capacity to control their nuclear localization and transcriptional activity. Such mechanisms may include post-translational modifications of Su(fu) itself, changes in the protein-protein interaction dynamics within the Hedgehog signaling complex, or the modulation of Su(fu) expression levels. Additionally, the competitive binding of other molecular partners or the alteration of Su(fu) subcellular localization can serve as effective strategies to inhibit its regulatory function. These inhibitory processes are critical for understanding the nuanced control of Hedgehog signaling, particularly in contexts where increased pathway activity is desired, such as in tissue repair and regeneration. Conversely, aberrant inhibition of Su(fu) could lead to pathological activation of Hedgehog signaling, highlighting the need for precise control mechanisms. The study of Su(fu) inhibition thus provides valuable insights into the sophisticated regulatory networks that govern cellular signaling pathways, offering avenues for research into developmental biology and disease mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Cyclopamine is a known inhibitor of the Hedgehog (Hh) signaling pathway, functioning by targeting Smoothened (SMO). This can indirectly inhibit Su(fu) by modulating the Hh pathway. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
Vismodegib is an antagonist of Smoothened, a key component of the Hh pathway, and can indirectly inhibit Su(fu) activity. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
GANT61 targets Gli transcription factors downstream in the Hh pathway, potentially influencing Su(fu) indirectly by altering the pathway's signaling. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Erismodegib, another Smoothened antagonist, can indirectly inhibit Su(fu) by modulating Hh signaling. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
Jervine, like Cyclopamine, is a Hedgehog pathway inhibitor that targets Smoothened, potentially modulating Su(fu)'s regulatory role. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Itraconazole has shown to inhibit Smoothened and could indirectly affect Su(fu) by altering Hh pathway signaling. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Arsenic Trioxide can inhibit the Hh pathway, potentially affecting Su(fu) activity indirectly. | ||||||
SANT-1 | 304909-07-7 | sc-203253 | 5 mg | $132.00 | 5 | |
SANT-1 is a potent Smoothened antagonist, which can lead to indirect inhibition of Su(fu) by disrupting Hh pathway signaling. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin has been reported to inhibit the Hh pathway, potentially affecting Su(fu) activity indirectly. | ||||||
Saridegib | 1037210-93-7 | sc-507351 | 5 mg | $3500.00 | ||
Saridegib is another inhibitor of Smoothened, potentially affecting Su(fu) activity by modulating the Hh pathway. | ||||||